George Dona Maria, Lakshmanan Archana
Department of Histopathology and Cytology, Apollo Main Hospitals, Chennai, IND.
Department of Histopathology and Cytology, Apollo Cancer Center, Chennai, IND.
Cureus. 2024 Dec 5;16(12):e75161. doi: 10.7759/cureus.75161. eCollection 2024 Dec.
Background and objective Lymphomas can involve the gastrointestinal (GI) tract as a primary disease or as a secondary spread of systemic disease. The GI tract is a key site for extranodal lymphomas, with Hodgkin lymphoma (HL) and non-Hodgkin lymphoma (NHL) occurring in this region. This study aimed to analyze the demography, anatomic distribution, histological subtypes, and immunomorphological characteristics of all lymphomas with a primary GI presentation at a quaternary care hospital in southern India. Methods We conducted a retrospective study covering the period from 2018 to 2022 involving all cases of lymphomas with primary GI presentation. All the cases were categorized based on morphological and immunophenotypic criteria per the World Health Organization (WHO) 2022 classification of hematopoietic and lymphoid neoplasms. Data were analyzed by using the statistical software SPSS Statistics version 28.0 (IBM Corp., Armonk, NY). Results Out of 2,455 lymphoma cases diagnosed in the five-year study period, 156 presented with primary GI symptoms. Males constituted 113 (72.5%) cases and 43 (27.5%) patients were females. The stomach (n=81; 52%) was the most common site, followed by the small intestine (n=40; 27%), large intestine (n=33; 20%), and esophagus (n=2; 1%). Most lymphomas involving the GI tract were NHL (n=152; 97%), and the remaining included four (3%) cases of HL. Diffuse large B-cell lymphoma (DLBCL) was the most frequent (n=102; 65.3%) B-cell NHL. Eight cases of T-cell lymphomas were noted including rare entities. Conclusions This study is one of the largest of its kind involving lymphomas with primary GI presentation from India. The distribution and incidence of various entities in our study were comparable to various other studies from India and those from Western countries. GI lymphomas are heterogeneous, with distinct prognoses and treatment strategies. Hence, diagnosing them correctly would help in prognostication and providing prompt therapy.
背景与目的 淋巴瘤可作为原发性疾病累及胃肠道(GI),也可作为系统性疾病的继发性扩散部位。胃肠道是结外淋巴瘤的关键部位,霍奇金淋巴瘤(HL)和非霍奇金淋巴瘤(NHL)均可发生于此区域。本研究旨在分析印度南部一家四级护理医院中所有以胃肠道为首发表现的淋巴瘤的人口统计学、解剖分布、组织学亚型及免疫形态学特征。方法 我们进行了一项回顾性研究,涵盖2018年至2022年期间所有以胃肠道为首发表现的淋巴瘤病例。所有病例均根据世界卫生组织(WHO)2022年造血与淋巴组织肿瘤分类的形态学和免疫表型标准进行分类。使用统计软件SPSS Statistics 28.0版(IBM公司,纽约州阿蒙克)进行数据分析。结果 在为期五年的研究期间诊断的2455例淋巴瘤病例中,156例以胃肠道症状为首发表现。男性占113例(72.5%),女性患者43例(27.5%)。胃(n = 81;52%)是最常见的部位,其次是小肠(n = 40;27%)、大肠(n = 33;20%)和食管(n = 2;1%)。累及胃肠道的大多数淋巴瘤为NHL(n = 152;97%),其余包括4例(3%)HL。弥漫性大B细胞淋巴瘤(DLBCL)是最常见的(n = 102;65.3%)B细胞NHL。记录到8例T细胞淋巴瘤,包括罕见类型。结论本研究是印度同类研究中规模最大的之一,涉及以胃肠道为首发表现的淋巴瘤。我们研究中各种类型淋巴瘤的分布和发病率与印度其他研究以及西方国家的研究结果相当。胃肠道淋巴瘤具有异质性,预后和治疗策略各不相同。因此,正确诊断有助于预后评估并及时提供治疗。